The Hippo

HOME| ADVERTISING | CONTACT US|

Stem Cells for Heart Bypass Results Manchester NH

Patients who received bone marrow stem cell transplants during coronary bypass surgery (CABG) experienced "excellent long-term safety and survival," say German researchers, who also noted the first promising results for stem cell transplantation during mitral valve repair.

Carl M Fier
(603) 627-1669
1 Elliot Way
Manchester, NH
Specialty
Cardiology

Data Provided by:
Robert Michael Lavery, MD
(603) 627-1669
1 Elliot Way Ste 100
Manchester, NH
Specialties
Cardiology
Gender
Male
Education
Medical School: Johns Hopkins Univ Sch Of Med, Baltimore Md 21205
Graduation Year: 1976

Data Provided by:
Carl Michael Fier, MD
(603) 627-1669
1 Elliot Way Ste 100
Manchester, NH
Specialties
Cardiology
Gender
Male
Education
Medical School: Mt Sinai Sch Of Med Of The City Univ Of Ny, New York Ny 10029
Graduation Year: 1994

Data Provided by:
Alan E Garstka
(603) 627-1669
1 Elliot Way
Manchester, NH
Specialty
Cardiology, Internal Medicine

Data Provided by:
Patrick V Hickle
(603) 627-1669
1 Elliot Way
Manchester, NH
Specialty
Cardiology, Cardiovascular Disease

Data Provided by:
Robert M LaVery
(603) 627-1669
1 Elliot Way
Manchester, NH
Specialty
Cardiology

Data Provided by:
Alan E Garstka, MD
(603) 627-1669
1 Elliot Way Ste 100
Manchester, NH
Specialties
Cardiology
Gender
Male
Education
Medical School: Univ Of Ma Med Sch, Worcester Ma 01655
Graduation Year: 1977

Data Provided by:
Robert Wetherell Orr, MD
(603) 627-1669
1 Elliot Way Ste 100
Manchester, NH
Specialties
Cardiology
Gender
Male
Education
Medical School: St George'S Univ, Sch Of Med, St George'S, Grenada
Graduation Year: 1984

Data Provided by:
Dr.PATRICK HICKLE
(603) 627-1669
1 Elliot Way # 100
Manchester, NH
Gender
M
Education
Medical School: Georgetown Univ Sch Of Med
Year of Graduation: 1990
Speciality
Cardiologist
General Information
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 1, reviews.

Data Provided by:
Robert W Orr
(603) 627-1669
1 Elliot Way
Manchester, NH
Specialty
Cardiology

Data Provided by:
Data Provided by:

Stem Cells for Heart Bypass Results

Provided By:

TUESDAY, Nov. 17 (HealthDay News) -- Patients who received bone marrow stem cell transplants during coronary bypass surgery (CABG) experienced "excellent long-term safety and survival," say German researchers, who also noted the first promising results for stem cell transplantation during mitral valve repair.

The study included 35 patients who received CD 133+ bone marrow stem cell transplantation during CABG, 20 patients who received only CABG surgery and 10 patients who received stem cell transplantation after mitral valve repair.

Long-term survival among patients in the stem cell transplant/CAGB group was up to five years. Three patients in the stem cell/mitral valve repair group died six months to a year after surgery, including two who developed progressive heart failure, the researchers noted.

The University of Rostock researchers found no sustained or adverse tissue changes in the patients who received stem cell transplants. The stem cell/CABG patients scored better on assessments of clinical effects than those who had only CABG surgery. Both CABG groups had preserved ventricular function, but left ventricular end diastolic volume decreased in the stem cell/CABG patients.

Decreased left ventricular end diastolic volume was also noted in the stem cell/mitral valve repair patients. Two years after the procedure, improved heart function was seen in these patients.

Blood flow scores increased significantly for CABG and mitral valve repair patients who received stem cell transplants, the study authors noted.

The study was to be presented Tuesday at the American Heart Association's annual meeting in Orlando, Fla.

More information

The Society of Thoracic Surgeons has more about CABG.

SOURCE: American Heart Association, news release, Nov. 17, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

®2010 Hippo Press. site by wedu